52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia

    Chih-Chang Chou, Peng Cheng, Hsin‐Hung Chen, Kuan Hung Chen, Ching‐Tang Wu, Jing Jiao, Chien‐Tsong Lin
    Image of study
    TLDR AH-001 could be a safer and more effective treatment for hair loss.
    The study introduces AH-001, a novel androgen receptor degrader, as a promising treatment for androgenetic alopecia (AGA). AH-001 effectively targets and degrades AR protein, showing potent efficacy in VCaP cells and reversing hair loss in a murine AGA model with minimal systemic exposure. Importantly, AH-001 did not cause serious adverse effects even at high doses in rats and showed no local skin irritation, addressing common side effects of current AGA treatments like minoxidil and finasteride. This suggests AH-001 has significant therapeutic potential for managing AGA.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 553 results

    Similar Research

    5 / 1000+ results